News Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Market Closed - OTC Markets Other stock markets 01:26:51 27/04/2024 am IST			5-day change	1st Jan Change
0.001 ^USD	-9.09%		-9.09%	-91.67%

16/04	Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	CI
16/04	Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Propanc Biopharma : Material Agreement - Form 8-K	22/04	PU
Propanc Biopharma Receives Certificate of Grant for Composition of Proenzymes for Cancer Treatment Patent from European Patent Office	17/04	AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	16/04	CI
Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC	16/04	CI
Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment, an inside Look at Drug Development and Strategic Financing	09/04	AQ
Propanc Biopharma : Material Agreement - Form 8-K	12/03	PU
Propanc Biopharma, Inc. announced that it has received $0.046875 million in funding	01/03	CI
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study	23/02	AQ
Propanc Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	21/02	CI
Propanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Office	16/01	CI
Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP	14/12	AQ
Propanc Biopharma, Inc. announced that it has received $0.135 million in funding	11/12	CI
Propanc Biopharma, Inc. announced that it has received $0.045 million in funding	04/12	CI
Propanc Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	15/11	CI
Propanc Biopharma, Inc. announced that it has received $0.04 million in funding	29/23/29	CI
Propanc Biopharma, Inc. announced that it expects to receive $0.04 million in funding	20/23/20	CI
Propanc Biopharma, Inc. announced that it has received $0.0575 million in funding from GS Capital Partners LLC	16/23/16	CI
Propanc Biopharma, Inc. announced that it expects to receive $0.0575 million in funding from GS Capital Partners LLC	12/23/12	CI
Propanc Biopharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	29/23/29	CI
Propanc Biopharma, Inc. announced that it has received $0.055 million in funding	31/23/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Summary

Filters